E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line

Oncogene

Volumn 24, Issue 21, 2005, Pages 3525-3534

  Wong, Chung Fai ^a   Barnes, Liam M ^a   Dahler, Alison L ^a   Smith, Louise ^a   Popa, Claudia ^a   Serewko Auret, Magdalena M ^a   Saunders, Nicholas A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Differentiation therapy; E2F; Keratinocytes; Sp1; Squamous cell carcinoma

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; E2F1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSGLUTAMINASE 1; TUMOR MARKER;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KERATINOCYTE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; PATHOLOGY; UPREGULATION;

CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; DOWN-REGULATION; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATINOCYTES; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 19444371383     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208372     Document Type: Article

References (45)

1. Andersen B, Schonemann MD, Flynn SE, Pearse II RV, Singh H and Rosenfeld MG. (1993). Science, 260, 78-82.
2. Apt D, Watts RM, Suske G and Bernard HU. (1996). Virology, 224, 281-291.
3. Banks EB, Crish JF, Welter JF and Eckert RL. (1998). Biochem. J., 331 (Part 1), 61-68.
4. Chen TT, Wu RL, Castro-Munozledo F and Sun TT. (1997). Mol. Cell. Biol., 17, 3056-3064.
5. Dahler AL, Cavanagh LL and Saunders NA. (2001). J. Invest. Dermatol., 116, 266-274.
6. Dahler AL, Jones SJ, Dicker AJ and Saunders NA. (1998). J. Cell. Physiol., 177, 474-482.
7. Di Stefano L, Jensen MR and Helin K. (2003). EMBO J., 22, 6289-6298.
8. Dicker AJ, Popa C, Dahler AL, Serewko MM, Hilditch-Maguire PA, Frazer IH and Saunders NA. (2000a). Oncogene, 19, 2887-2894.
9. Dicker AJ, Serewko MM, Dahler AL, Khanna KK, Kaur P, Li A, Strutton GM and Saunders NA. (2000b). Exp. Cell Res., 258, 352-360.
10. Dignam JD, Lebovitz RM and Roeder RG. (1983). Nucleic Acids Res., 11, 1475-1489.
11. Eckert RL, Crish JF, Banks EB and Welter JF. (1997a). J. Invest. Dermatol., 109, 501-509.
12. Eckert RL, Crish JF and Robinson NA. (1997b). Physiol. Rev., 77, 397-424.
13. Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA and Auwerx J. (2002). Dev. Cell, 3, 39-49.
14. Guo CS, Degnin C, Fiddler TA, Stauffer D and Thayer MJ. (2003). J. Biol. Chem., 278, 22615-22622.
15. Guy CT, Zhou W, Kaufman S and Robinson MO. (1996). Mol. Cell. Biol., 16, 685-693.
16. Hagen G, Muller S, Beato M and Suske G. (1994). EMBO J., 13, 3843-3851.
17. Helin K, Lees JA, Vidal M, Dyson N, Harlow E and Fattaey A. (1992). Cell, 70, 337-350.
18. Jang SI and Steinert PM. (2002). J. Biol. Chem., 277, 42268-42279.
19. Jessen BA, Phillips MA, Hovnanian A and Rice RH. (2000). J. Invest. Dermatol., 115, 113-117.
20. Johnson-Pais T, Degnin C and Thayer MJ. (2001). Proc. Natl. Acad. Sci. USA, 98, 2211-2216.
21. Jones SJ, Dicker AJ, Dahler AL and Saunders NA. (1997). J. Invest. Dermatol., 109, 187-193.
22. Kadonaga JT, Garner KR, Masiarz FR and Tjian R. (1987). Cell, 51, 1079-1090.
23. Karlseder J, Rotheneder H and Wintersberger E. (1996). Mol. Cell. Biol., 16, 1659-1667.
24. Khanna KK, Beamish H, Yan J, Hobson K, Williams R, Dunn I and Lavin MF. (1995). Oncogene, 11, 609-618.
25. Kingsley C and Winoto A. (1992). Mol. Cell. Biol., 12, 4251-4261.
26. Lane EB, Bartek J, Purkis PE and Leigh IM. (1985). Ann. NY Acad. Sci., 455, 241-258.
27. Lania L, Majello B and De Luca P. (1997). Int. J. Biochem. Cell Biol., 29, 1313-1323.
28. Lee JH, Jang SI, Yang JM, Markova NG and Steinert PM. (1996). J. Biol. Chem., 271, 4561-4568.
29. Medvedev A, Saunders NA, Matsuura H, Chistokhina A and Jetten AM. (1999). J. Biol. Chem., 274, 3887-3896.
30. Park GT and Morasso MI. (1999). J. Biol. Chem., 274, 26599-26608.
31. Phillips MA, Jessen BA, Lu Y, Qin Q, Stevens ME and Rice RH. (2004). BMC Dermatol., 4, 2.
32. Pierce AM, Fisher SM, Conti CJ and Johnson DG. (1998). Oncogene, 16, 1267-1276.
33. Popa C, Dahler AL, Serewko-Auret MM, Wong CF, Smith L, Barnes LM, Saunders NA and Strutton GM. (2004). Differentiation, 72, 185-197.
34. Popa C, Dicker AJ, Dahler AL and Saunders NA. (1999). Br. J. Dermatol., 141, 460-468.
35. Rieger M and Franke WW. (1988). J. Mol. Biol., 204, 841-856.
36. Saunders NA, Bernacki SH, Vollberg TM and Jetten AM. (1993a). Mol. Endocrinol., 7, 387-398.
37. Saunders NA, Smith RJ and Jetten AM. (1993b). Biochem. Biophys. Res. Commun., 197, 46-54.
38. Serewko MM, Popa C, Dahler AL, Smith L, Strutton GM, Coman W, Dicker AJ and Saunders NA. (2002). Cancer Res., 62, 3759-3765.
39. Trimarchi JM and Lees JA. (2002). Nat. Rev. Mol. Cell. Biol., 3, 11-20.
40. Wang J, Helin K, Jin P and Nadal-Ginard B. (1995). Cell Growth Differ., 6, 1299-1306.
41. Weinberg RA. (1995). Cell, 81, 323-330.
42. Wong CF, Barnes LM, Dahler AL, Smith L, Serewko-Auret MM, Popa C, Abdul-Jabbar I and Saunders NA. (2003). J. Biol. Chem., 278, 28516-28522.
43. Wong CF, Barnes LM, Smith L, Popa C, Serewko-Auret MM and Saunders N. (2004). Biochem. Biophys. Res. Commun., 324, 497-503.
44. Woodworth CD, Wang H, Simpson S, Alvarez-Salas LM and Notario V. (1993). Cell Growth Differ., 4, 367-376.
45. Wu RL, Chen TT and Sun TT. (1994). J. Biol. Chem., 269, 28450-28459.